Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: Using a new immunoprecipitation assay

Clinical Chemistry and Laboratory Medicine

Volumn 55, Issue 7, 2017, Pages 1003-1012

  Larosa, Maria Del Pilar ^a   Mackenzie, Rachel ^a   Burne, Peter ^a   Garelli, Silvia ^b   Barollo, Susi ^b   Masiero, Stefano ^b   Rubin, Beatrice ^b   Chen, Shu ^a   Furmaniak, Jadwiga ^a   Betterle, Corrado ^b   Smith, Bernard Rees ^a  

^a RSR LTD   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

AIRE gene; APS 1; autoimmunity; interferon Ab

Indexed keywords

AUTOANTIBODY; AUTOIMMUNE REGULATOR PROTEIN; BIOLOGICAL MARKER; INTERFERON; INTERFERON ANTIBODY; INTERFERON OMEGA; INTERFERON OMEGA AUTOANTIBODY; IODINE 125; P450 SIDE CHAIN CLEAVAGE ENZYME AUTOANTIBODY; STEROID 21 HYDROXYLASE AUTOANTIBODY; UNCLASSIFIED DRUG; INTERFERON OMEGA 1; TRANSCRIPTION FACTOR;

ADDISONS DISEASE AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 4; ADOLESCENT; ADRENAL DISEASE; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 2; CELIAC DISEASE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; FEMALE; FIRST-DEGREE RELATIVE; FOLLOW UP; GENE MUTATION; GENOTYPE; GRAVES DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISSENSE MUTATION; MULTIPLE SCLEROSIS; MUTATIONAL ANALYSIS; MYASTHENIA GRAVIS; PHENOTYPE; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; GENETICS; IMMUNOLOGY; IMMUNOPRECIPITATION; ISOLATION AND PURIFICATION; MUTATION; POLYENDOCRINOPATHY; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; IMMUNOPRECIPITATION; INTERFERON TYPE I; MALE; MIDDLE AGED; MUTATION; POLYENDOCRINOPATHIES, AUTOIMMUNE; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 85020522491     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2016-0615     Document Type: Article

References (25)

1. The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997;717:399-403.
2. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, et al. Positional cloning of the APECED gene. Nat Genet 1997;17:393-8.
3. Meager, A, Visvalingam K, Peterson P, Möll K, Murumägi A, Krohn K, et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathysyndrome type 1. PLoS Med 2006;3:e289.
4. Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, et al. Autoantibodies against type I interferon as an additional diagnostic criterion for autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 2008;93:4389-97.
5. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002;298:1395-401.
6. Betterle C, Greggio NA, Volpato M. Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1998;83:1049-55.
7. Perheentupa J. Autoimmune polyendocrinopathy-candidiasisectodermal dystrophy. J Clin Endocrinol Metab 2006;91:2843-50.
8. Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J Clin Immunol 2015;35:463-78.
9. Husebye ES, Perheentupa J, Rautemaa R, Kämpe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type 1. J Int Med 2009;265:514-29.
10. Betterle C, Presotto F. Autoimmune polyendocrine syndromes (APS) or multiple autoimmune syndromes (MAS). In: Walker S, Jara LJ, editors. Handbook of systemic autoimmune diseases, volume 9. Endocrine manifestations of systemic autoimmune diseases. Amsterdam: Elsevier BV, 2008:135-48.
11. 131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963;89:114-23.
12. Cervato S, Morlin L, Albergoni MP, Masiero S, Greggio N, Meossi C, et al. AIRE gene mutations and autoantibodies to interferon omega in patients with chronic hypoparathyroidism without APECED. Clin Endocrinol 2010;73:630-6.
13. Tanaka H, Perez MS, Powell M, Sanders JF, Sawicka J, Chen S, et al. Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay. J Clin Endocrinol Metab 1997;82:1440-6.
14. Falorni A, Bini V, Betterle C, Brozzetti A, Castaño L, Fichna M, et al. Determination of 21-hydroxylase autoantibodies: interlaboratory concordance in the Euradrenal International Serum Exchange Program. Clin Chem Lab Med 2015;53:1761-70.
15. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease and premature ovarian failure. J Clin Endocrinol Metab 1996;81:1871-6.
16. Dal Pra C, Chen S, Betterle C, Zanchetta R, McGrath V, Furmaniak J, et al. Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase. Eur J Endocrinol 2004;150:313-21.
17. Cervato S, Mariniello B, Lazzarotto F, Morlin L, Zanchetta R, Radetti G, et al. Evaluation of the AIRE gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives. Clin Endocrinol 2009;70:421-8.
18. Breivik L, Oftedal BE, Bøe Wolff AS, Bratland E, Orlova EM, Husebye ES. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1. Clin Immunol 2014;153:220-7.
19. Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, et al. A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin Immunol 2007;125:131-7.
20. Oftedal BE, Wolff AS, Bratland E, Kämpe O, Perheentupa J, Myhre AG, et al. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clin Immunol 2008;129:163-9.
21. Capalbo D, De Martino L, Giardino G, Di Mase R, Di Donato I, Parenti G, et al. Autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy: insights into genotype-phenotype correlation. Int J Endocrinol 2012;2012:353250.
22. Bluestone JA. Mechanism of tolerance. Immunol Rev 2011;241:5-49.
23. Matsuo T, Noguchi Y, Shindo M, Morita Y, Oda Y, Yoshida E, et al. Regulation of human autoimmune regulator (AIRE) gene translation by miR-220b. Gene 2013;530:19-25.
24. Meager A, Wadhwa M, Dilger P, Bird C, Thorpe R, Newsom-Davis J, et al. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interpheron-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin Exp Immunol 2003;132:128-36.
25. Slavikova M, Schmeisser H, Kontsekova E, Mateicka F, Borecky L, Kontsek P. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia. J Interferon Cytokine Res 2003;23:143-7.